Dataset Information

Proteomics analysis of lipid-induced granules

ABSTRACT: During the processes of MAFLD and MASH, DDX49 undergoes liquid-liquid phase separation. Subsequently, we used OA/PA (2:1) to simulate the MASH model in vitro. After treating HHL5 cells with OA/PA for 24 hours, we separated the lipid-organized particles of DDX49 by differential centrifugation. To investigate the composition of these particles and study their functions, we conducted a 10-fold proteomic analysis.

INSTRUMENT(S):

ORGANISM(S): Homo Sapiens (human)

TISSUE(S): Hepatocyte, Cell Culture

SUBMITTER: Yunhui Li

LAB HEAD: Yunhui Li

PROVIDER: PXD064747 | Pride | 2026-01-09

REPOSITORIES: Pride

ACCESS DATA

Dataset's files

Source:

Items per page:

1 - 5 of 5

Similar Datasets

Project description:Metabolic dysfunction-associated steatotic liver disease (MASLD) is estimated to affect approximately 30% of adults worldwide. The progressive form of MASLD, namely metabolic-dysfunction steatohepatitis (MASH), is a leading cause of chronic liver disease. MASH is marked by hepatocellular fat accumulation (steatosis), ballooning, and inflammation. Although many in vitro and in vivo models replicate MASH pathophysiology, no in vitro hepatocyte MASH model has been evaluated for its ability to reflect clinically observed changes in drug metabolizing enzyme (DME) and transporter characteristics such as abundance and activity. This study addressed this knowledge gap by developing a model using sandwich-cultured human hepatocytes (SCHH) that mimics both MASH pathophysiology and alterations in DME and transporter concentrations and function. Lipid-cytokine treatments were first optimized using differentiated HuH-7 cells based on cellular toxicity profiles and their ability to induce a MASH-like phenotype. Three final treatments, all including TNF-α (1 ng/mL) and IL-6 (1.2 ng/mL), were selected for evaluation in SCHH: (1) oleic acid (OA):palmitic acid (PA) (1:2, 0.5 mM), (2) a lipid mix (lysophospholipids mixture + OA:PA), and (3) lipid mix+0.01 mM cholesterol. Treatments were incubated for 72 h with SCHH from three donors. Quantitative targeted absolute proteomics (QTAP), employing stable isotope labeled (SIL) peptide standards and microLC-MS/MS measurement, was used to quantify transporter and DME concentrations in the SCHH total membrane fraction. Concentrations of ten transporters, ten CYP450s, seven UGTs and five other DMEs could be measured above the lower limit of quantification of 0.1 pmol/mg membrane protein. B-CLEAR® technology was used, also, to evaluate transporter function with [3H]-taurocholate (TCA) and [3H]-estradiol-17β-glucuronide (E217G) employed as probe substrates of function. All three treatments significantly increased lipid droplet formation and peroxidation, characteristics of MASH, in SCHH with minimal toxicity. The treatments also altered DME and transporter concentrations in a similar manner to changes observed in liver tissue from patients with MASH. Across treatments, concentrations of bile salt export pump (BSEP), sodium taurocholate co-transporting polypeptide (NTCP), organic anion transporting polypeptide (OATP) 1B1, OATP1B3, and multidrug resistance-associated protein (MRP) 2 were reduced by 0.66–0.57-fold, 0.71–0.52-fold, 0.74–0.63-fold, 0.82–0.80-fold, and 0.71–0.48-fold, respectively. Correspondingly, TCA apparent uptake clearance and biliary clearance were reduced by 0.70–0.26-fold and 0.61–0.27-fold, respectively. E217G apparent uptake clearance was reduced by 0.67–0.35-fold while biliary excretion index values for E217G were reduced to negligible levels. Overall, the findings demonstrate that lipid–cytokine treatments induce MASH-like changes in SCHH, including clinically relevant reductions in DME and transporter concentrations and transporter function. This model may serve as a valuable tool for predicting altered hepatobiliary drug disposition in MASH.

			Action	DRS
	OAPA1.zip	Other
	OAPA2.zip	Other
	XB05500DI_OAPA1_Slot1-20_1_6483.d.zip	Other
	XB05500DI_OAPA2_Slot1-21_1_6485.d.zip	Other
	checksum.txt	Txt

Dataset Information

Proteomics analysis of lipid-induced granules

Dataset's files

Similar Datasets

OmicsDI is part of the ELIXIR infrastructure

Tweets